Lab Owl®: A True Growth Accelerator for
Cost Effective Bioreactor Control System Yields Wide Array Benefits for Leading Gene-to-Protein Service Provider
In March 2019, Kempbio announced that it had been acquired by Six.02 Bioservices and was subsequently relaunched as Kemp Proteins. The acquisition, and the consistent success that led up to it, reflect Kemp Proteins’ status as a leading growth-stage bioservices organization.
Like any company, Kemp Proteins needed to maximize its return on investment. To properly fit-out its newly expanding lab space, the organization purchased seven refurbished, high-end brand bioreactor units for protein development. Acquiring this equipment was an initial boon for the company as it was getting top-line bioreactors at significantly less cost. However, getting these refurbished bioreactors of different makes and models to communicate became a daunting and unexpected challenge.
Kemp Proteins heard high praise of Lab Owl from other respected life science companies and the two teams joined forces to solve these bioreactor challenges.
What Kemp Proteins is Saying...
Two Major Lab Owl® Features
that Set Up Kemp Proteins for Future Growth….
Like any emerging life science company, maximizing budget dollars is critical. The Lab Owl team worked with Kemp Proteins to maximize their investment in refurbished lab equipment by linking and automating equipment of different makes, models, and capabilities to operate within a single, integrated control system.
Kemp Protein’s refurbished lab equipment, which could not communicate previously, was transformed into a user-friendly, intuitive system that has helped the organization build-out standard operating procedures, increase process reliability and predictability and streamline training and knowledge sharing across its lab team.